TNFRSF4 and acute myeloid leukemia: Additionally, high RNA expression of the OX40 gene/TNFRSF4 gene from the TCGA database in AML patients was associated with TP53, FLT3, and NPM1 mutation and unfavorable clinical outcome [46].